Axim Biotechnologies has initiated a clinical trial of its non-prescription hemp-derived cannabinoid functional chewing gum for the treatment of patients with irritable bowel syndrome.
WeedLife News Network
Hot off the press cannabis, marijuana, cbd and hemp news from around the world on the WeedLife Social Network.